IBDEI16J ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21091,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,21091,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,21091,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,21092,0)
 ;;=V10.85^^118^1265^3
 ;;^UTILITY(U,$J,358.3,21092,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21092,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,21092,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,21092,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,21093,0)
 ;;=V10.86^^118^1265^26
 ;;^UTILITY(U,$J,358.3,21093,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21093,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,21093,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,21093,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,21094,0)
 ;;=V10.88^^118^1265^16
 ;;^UTILITY(U,$J,358.3,21094,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21094,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,21094,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,21094,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,21095,0)
 ;;=238.0^^118^1266^1
 ;;^UTILITY(U,$J,358.3,21095,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21095,1,1,0)
 ;;=1^238.0
 ;;^UTILITY(U,$J,358.3,21095,1,8,0)
 ;;=8^Bone and Articular Cartilage
 ;;^UTILITY(U,$J,358.3,21095,2)
 ;;=^81953
 ;;^UTILITY(U,$J,358.3,21096,0)
 ;;=238.1^^118^1266^3
 ;;^UTILITY(U,$J,358.3,21096,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21096,1,1,0)
 ;;=1^238.1
 ;;^UTILITY(U,$J,358.3,21096,1,8,0)
 ;;=8^Connective and Oth Soft Tissue
 ;;^UTILITY(U,$J,358.3,21096,2)
 ;;=^267776
 ;;^UTILITY(U,$J,358.3,21097,0)
 ;;=238.2^^118^1266^17
 ;;^UTILITY(U,$J,358.3,21097,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21097,1,1,0)
 ;;=1^238.2
 ;;^UTILITY(U,$J,358.3,21097,1,8,0)
 ;;=8^Skin
 ;;^UTILITY(U,$J,358.3,21097,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,21098,0)
 ;;=238.3^^118^1266^2
 ;;^UTILITY(U,$J,358.3,21098,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21098,1,1,0)
 ;;=1^238.3
 ;;^UTILITY(U,$J,358.3,21098,1,8,0)
 ;;=8^Breast
 ;;^UTILITY(U,$J,358.3,21098,2)
 ;;=^81956
 ;;^UTILITY(U,$J,358.3,21099,0)
 ;;=238.4^^118^1266^15
 ;;^UTILITY(U,$J,358.3,21099,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21099,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,21099,1,8,0)
 ;;=8^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,21099,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,21100,0)
 ;;=238.5^^118^1266^6
 ;;^UTILITY(U,$J,358.3,21100,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21100,1,1,0)
 ;;=1^238.5
 ;;^UTILITY(U,$J,358.3,21100,1,8,0)
 ;;=8^Histiocytic and Mast Cells
 ;;^UTILITY(U,$J,358.3,21100,2)
 ;;=^267778
 ;;^UTILITY(U,$J,358.3,21101,0)
 ;;=238.6^^118^1266^14
 ;;^UTILITY(U,$J,358.3,21101,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21101,1,1,0)
 ;;=1^238.6
 ;;^UTILITY(U,$J,358.3,21101,1,8,0)
 ;;=8^Plasma Cells
 ;;^UTILITY(U,$J,358.3,21101,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,21102,0)
 ;;=238.71^^118^1266^4
 ;;^UTILITY(U,$J,358.3,21102,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21102,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,21102,1,8,0)
 ;;=8^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,21102,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,21103,0)
 ;;=238.72^^118^1266^7
 ;;^UTILITY(U,$J,358.3,21103,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21103,1,1,0)
 ;;=1^238.72
 ;;^UTILITY(U,$J,358.3,21103,1,8,0)
 ;;=8^Low Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,21103,2)
 ;;=^334028
 ;;^UTILITY(U,$J,358.3,21104,0)
 ;;=238.73^^118^1266^5
 ;;^UTILITY(U,$J,358.3,21104,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,21104,1,1,0)
 ;;=1^238.73
 ;;^UTILITY(U,$J,358.3,21104,1,8,0)
 ;;=8^High Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,21104,2)
 ;;=^334029
